Steven Seedhouse

Stock Analyst at Raymond James

(0)
# 4786
Out of 5,347 analysts
264
Total ratings
30.23%
Success rate
-21.96%
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
MIRM Mirum Pharmaceutical...
Maintains: Strong Buy
73 77
44.45 73.23% 19 May 13, 2025
WVE WAVE Life Sciences
Initiates Coverage On: Overweight
10
6.01 66.39% 3 Apr 29, 2025
KRRO Korro Bio
Initiates Coverage On: Overweight
74
11.46 545.72% 2 Apr 29, 2025
PHVS Pharvaris
Initiates Coverage On: Overweight
28
16.44 70.32% 1 Apr 29, 2025
ATXS Astria Therapeutics
Initiates Coverage On: Overweight
47
4.77 885.32% 1 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
10
0.8 1150% 14 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
20
10.74 86.22% 1 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
104
26.82 287.77% 19 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
90 22
1.73 1171.68% 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
51 56
17.41 221.65% 3 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
53 49
9.84 397.97% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
6 14
1.66 743.37% 6 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
93
110.02 -15.47% 9 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
57 68
18.94 259.03% 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 11 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33 33
n/a n/a 12 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
67 106
16.93 526.11% 15 Jan 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 15
3.67 308.72% 2 Jan 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 56
11.98 367.45% 4 Jan 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 18
0.38 4505.26% 8 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 57
6.86 730.9% 10 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
20 22
1.01 2078.22% 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
17
1.73 882.66% 6 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 17 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 35
2.51 1294.42% 4 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
38
29.64 28.21% 2 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 6
n/a n/a 7 Apr 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 10 Feb 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 71
30.94 129.48% 4 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 5
1.11 350.45% 5 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 38
22.21 71.09% 2 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Aug 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 7 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 14 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 May 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
285 270
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 10
n/a n/a 3 Mar 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 10 Jan 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Apr 23, 2020